Traduction de «compound amount factor » (Anglais → Français) :

compounding factor for 1 [ compound interest factor | amount of one | compounding factor ]

remaining principal amount factor | RPA factor | RPB factor | remaining principal balance factor

compound amount [ compound sum | future value ]

future value factor | capitalization factor | compound factor | FVF

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

Definition: Hypersomnia is defined as a condition of either excessive daytime sleepiness and sleep attacks (not accounted for by an inadequate amount of sleep) or prolonged transition to the fully aroused state upon awakening. In the absence of an organic factor for the occurrence of hypersomnia, this condition is usually associated with mental disorders.

additional amounts or factors

factor (in taxable amount)

compounding factor

The amount of non-carbonate compounds of the relevant metals in the raw materials, including return dust or fly ash or other already calcined materials, shall be reflected by means of conversion factors with a value between 0 and 1 with a value of 1 corresponding to a full conversion of raw material carbonates into oxides.

I suppose there was a cost factor associated with the structure of an independent secretariat to provide a neutral forum for conducting negotiations regarding self-governance (1640) I remind the committee of the cost factor associated with doing nothing, which is what has happened in the last 20 years the total aggregate amount of money wasted and the social costs associated with doing nothing, of leaving the situations of poverty, poor health, poor housing, and compounding ...[+++] social.all the predictable consequences of chronic, long-term poverty, either on reserves or as they manifest themselves in the inner cities, where we find first nations people completely marginalized from the mainstream economy all the predictable costs associated with that.

In designing the PAFT program, factors considered were safety, an urgent need for toxicology information, availability of the compounds in amounts sufficient to sustain long-term tests, the economic future of these alternatives, and the availability of space for inhalation studies in qualified toxicology laboratories.